BTK-IN-18 is a potent, reversible BTK inhibitor with an IC 50 of 0.002 µM. BTK-IN-18 inhibits both CD69 and CD86 in vivo.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Btk
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.